• I-Desmopressin acetate yenaliti

    I-Desmopressin acetate yenaliti

    I-1ml: 4μg / 1ml: 15μg Isibonakaliso samandla: IZIbonakaliso NOKUSETYENZISWA I-Hemophilia A: I-Desmopress kwi-Acetate Injection 4 mcg / mL iboniswa kwizigulane ezine-hemophilia A kunye ne-factor VIII amanqanaba omsebenzi we-coagulant ngaphezu kwe-5%. I-Desmopress kwinaliti ye-acetate iya kuhlala igcina i-hemostasis kwizigulane ezine-hemophilia A ngexesha leenkqubo zotyando kunye nasemva kokuhlinzwa xa kulawulwa imizuzu engama-30 ngaphambi kwenkqubo ecwangcisiweyo. I-Desmopress kwinaliti ye-acetate iyakuyeka ukopha kwi-hemophilia A pat...
  • I-Telipressin acetate yenaliti

    I-Telipressin acetate yenaliti

    I-Terlipressin Acetate ye-injection ye-1mg / i-vial Amandla eSibonakaliso: Kunyango lwe-variceal ye-esophageal. Ukusetyenziswa kweklinikhi: inaliti ye-intravenous. I-Terlipress kwi-acetate EVER I-Pharma 0.2 mg/ml isisombululo sokutofa iqulethe isithako esisebenzayo i-terlipress in, eyi-hormone yokwenziwa kwe-pituitary (le hormone idla ngokuveliswa yi-pituitary gland efumaneka kwingqondo). Uya kunikwa ngokutofwa emithanjeni. Terlipress in acetate EVER Pharma 0.2 mg/ml ngoko...
  • Bivalirudin ukuba inaliti

    Bivalirudin ukuba inaliti

    I-Bivalirudin ye-injection ye-250mg / i-vial Isibonakaliso samandla: I-Bivalirudin iboniswa ukuba isetyenziswe njenge-anticoagulant kwizigulane ezithatha i-percutaneous coronary intervention (PCI). Ukusetyenziswa kweklinikhi:Isetyenziselwa inaliti ye-intravenous kunye nethonsi ye-intravenous. IZIbonakaliso NOKUSETYENZISWA 1.1 I-Percutaneous Transluminal Coronary Angioplasty (PTCA) I-Bivalirudin ye-Injection iboniswa ukuba isetyenziswe njenge-anticoagulant kwizigulane ezine-angina ezingazinzanga ezihamba nge-percutaneous transluminal coronary angiopla...